Fred Wininger, VMD, MS, DACVIM (Neurology), discussed some older seizure medications and other management therapies
While at the Fetch conference in Long Beach, California, Fred Wininger, VMD, MS, DACVIM (Neurology), sat down with dvm360 in an interview and explained some older anti-seizure medications and how they can still be used alongside newer treatment options. He also discussed how to find the best management therapy for your patients.
The following is a partial transcript of the video.
Fred Wininger, VMD, MS, DACVIM (Neurology): When it comes to anti-seizure medications 15 years ago, I would lecture about it. And nobody knew what [levetiracetam] (Keppra) was. And now Keppra is the initial monotherapy that a lot of my colleagues use. But I think we've forgotten that there's so much value in our tried and true anticonvulsants, specifically phenobarbital and potassium bromide. And so we're going to focus on the utility of those drugs, the synergy they have with some of our modern anticonvulsants and when they're best employed.
From exam room tips to practice management insights, get trusted veterinary news delivered straight to your inbox—subscribe to dvm360.
Torsemide for canine CHF: Emerging evidence and clinical benefits
June 5th 2025William Rausch, DVM, DACVIM (Cardiology), explains that torsemide offers at least equivalent efficacy to furosemide in canine CHF while significantly reducing short-term mortality/worsening events by approximately 50%.
Read More